Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionBoothbay Fund Management, Llc
Latest Disclosed Ownership88,379 shares
Latest Disclosed Value $ 2,661,975
Boothbay Fund Management, Llc ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On May 15, 2026 - Boothbay Fund Management, Llc filed a 13F-HR form disclosing ownership of 88,379 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $2,661,975 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 113,813 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of -22.35% during the quarter. The current value of the position is $3,021,678 USD.

Boothbay Fund Management, Llc has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options. The firm currently holds call options representing 41,700 of underlying shares valued at $1,256,004 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 88,379 -25,434 -22.35 2,662 -25.08 0.0345
2026-02-17 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 113,813 -85,841 -42.99 3,552 -11.93 0.0530
2025-11-14 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 199,654 17,486 9.60 4,033 32.10 0.0586
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 182,168 182,168 3,053 0.0593
2022-11-14 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -201,811 -100.00 0 -100.00
2022-08-15 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 201,811 110,263 120.44 1,518 76.51 0.0400
2022-05-16 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 91,548 12,636 16.01 860 36.08 0.0200
2022-02-14 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 78,912 78,912 632 0.0149
2020-08-14 2020-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -28,700 -100.00 0 -100.00
2020-05-15 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 28,700 28,700 258 0.0214
2020-02-14 2019-12-31 13F Teva Pharmaceutical Industries SPONSORED ADS 881624209 0 -62,430 -100.00 0 -100.00
2019-11-14 2019-09-30 13F Teva Pharmaceutical Industries SPONSORED ADS 881624209 62,430 62,430 430 0.0394
2017-07-18 2015-12-31 13F/A-3 TEVA PHARMACEUTICA INDS ADR 881624209 0 -5,899 -100.00 0 -100.00
2016-06-09 2015-09-30 13F/A-1 TEVA PHARMACEUTICAL INDS ADR 881624209 5,899 -2,715 -31.52 333 -34.58 0.3104
2015-11-16 2015-09-30 13F TEVA PHARMACEUTICA INDS ADR 881624209 5,899 333
2016-06-09 2015-06-30 13F/A-2 TEVA PHARMACEUTICAL INDS ADR 881624209 8,614 4,624 115.89 509 104.42 0.4976
2015-08-17 2015-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS ADR 881624209 8,614 0 509 0.2117
2015-08-14 2015-06-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 8,614 509
2016-06-09 2015-03-31 13F/A-2 TEVA PHARMACEUTICAL INDS ADR 881624209 3,990 3,990 249 0.3546
2015-06-10 2015-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS ADR 881624209 3,790 -200 236 0.2698
2015-05-15 2015-03-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 3,790 236
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 41,700 1,256 n/a n/a n/a
2026-02-17 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 58,600 0.00 1,184 20.47 n/a n/a n/a
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 58,600 0.00 982 9.11 n/a n/a n/a
2025-05-15 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 58,600 102.77 901 41.51 n/a n/a n/a
2025-02-14 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 28,900 637 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-11-14 2017-09-30 13F TEVA PHARMACEUTICAL SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F TEVA PHARMACEUTICAL SPONSORED ADR Put 34,000 1,129 n/a n/a n/a
2017-05-15 2017-03-31 13F TEVA PHARMACEUTICAL INDS ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-16 2016-12-31 13F/A TEVA PHARMACEUTICAL INDS ADR Put 8,200 297 n/a n/a n/a
2017-07-18 2016-12-31 13F/A TEVA PHARMACEUTICAL INDS ADR Put 8,200 297 n/a n/a n/a
2017-02-15 2016-12-31 13F TEVA PHARMACEUTICAL INDS ADR Put 82 5 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.